# Efficacy and Safety of Dihydroartemisinin/Piperaquine (Artekin®) for the Treatment of Uncomplicated Malaria in Peru

> **NCT00373607** · PHASE3 · COMPLETED · sponsor: **Institute of Tropical Medicine, Belgium** · enrollment: 522 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Dihydroartemisin-piperaquine
- **DRUG:** Mefloquine + Artesunate

## Key facts

- **NCT ID:** NCT00373607
- **Lead sponsor:** Institute of Tropical Medicine, Belgium
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** 2005-07
- **Final completion:** 2005-07
- **Target enrollment:** 522 (ACTUAL)
- **Last updated:** 2010-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00373607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00373607, "Efficacy and Safety of Dihydroartemisinin/Piperaquine (Artekin®) for the Treatment of Uncomplicated Malaria in Peru". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00373607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*